Solvonis’ Novel Compound SVN-015 Accepted into US NIDA-Funded Addiction Treatment Discovery Program for Methamphetamine and Cocaine Addiction
Graft Polymer (UK) (LON:GPL) Business Update
Update on Recent Developments
Solvonis’ Novel Compound SVN-015 Accepted into US NIDA-Funded Addiction Treatment Discovery Program for Methamphetamine and Cocaine Addiction
Update on Recent Developments